Medtronic developed Telescope in alliance with interventional cardiologists to enable improved and smooth delivery of interventional devices in complex cases. Credit: Medtronic plc.

Medtronic has globally launched its new guide extension catheter, Telescope, to deliver interventional devices such as coronary stents and balloons during angioplasty procedures.

The device has been designed to offer additional backup support and access to distal lesions.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Medtronic developed Telescope in alliance with interventional cardiologists to enable improved and smooth delivery of interventional devices in complex cases.

The guide extension catheter features a solid, round pushwire in combination with a coil-reinforced hydrophilic-coated distal segment to enable access to challenging lesions with better pushability and deliverability.

In addition, the device is integrated with a flexible TruFlexsoft polymer tip designed for bending and deflection during use.

It also includes SmoothPass technology for smooth channelling of stents, balloons and other interventional devices into place, after the catheter is in position near the target lesion.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Medtronic Coronary and Renal Denervation business vice-president and general manager Dave Moeller said: “Before bringing this important technology to market, we collaborated with more than 700 interventional cardiologists to ensure Telescope was addressing unmet needs in complex PCI.

“We will continue to make investments in cutting edge interventional technologies, clinical evidence expansion, and robust physician training programmes, which we believe will make a meaningful difference for physicians and their patients.”

“Before bringing this important technology to market, we collaborated with more than 700 interventional cardiologists to ensure Telescope was addressing unmet needs.”

The company’s coronary portfolio additionally includes Resolute Onyx drug-eluting stent (DES), Euphora pre- and post-dilatation balloon catheters range and a suite of catheters including the DxTerity TRA Diagnostic Catheter and Launcher Guide Catheter.

Earlier this month, Medtronic introduced Solitaire X, a revascularisation device intended to treat patients with acute ischemic stroke, in the US.

The device is meant for mechanical removal of blood clots from blocked vessels in the brain. Solitaire X is the company’s fourth generation device.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact